Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
04/17/14 Merck (MRK) Ragwitek for Allergic Rhinitis Subscribers Only Subscribers Only     Subscribers Only
04/17/14 GlaxoSmithKline (GSK) GSK2586184 for Psoriasis Subscribers Only Subscribers Only     Subscribers Only
04/17/14 GlaxoSmithKline (GSK) Arzerra for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only     Subscribers Only
04/17/14 Actelion (ATLN:VX) Selexipag for Pulmonary Arterial Hypertension (PAH) Subscribers Only Subscribers Only     Subscribers Only
04/16/14 Spectrum (SPPI) Belinostat (Oral) for Solid Tumors Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
04/17/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 04/18/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 04/18/14 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
Now - 04/18/14 Subscribers Only Subscribers Only Trial Announcement - Patient Enrollment Completed